IL-9 and NPM-ALK Cause Mast Cell Disease in Mice
Author Information
Author(s): Merz Hartmut, Kaehler Christian, Hoefig Kai P., Branke Biggi, Uckert Wolfgang, Nadrowitz Roger, Sabine-Cerny-Reiterer, Herrmann Harald, Feller Alfred C., Valent Peter
Primary Institution: Medical University of Schleswig-Holstein, Campus Luebeck, Germany
Hypothesis
Can IL-9 and NPM-ALK cooperate to induce mastocytosis-like disease in mice?
Conclusion
The study found that IL-9 and NPM-ALK together promote the development of a mastocytosis-like disease in mice.
Supporting Evidence
- Transplantation of NPM-ALK-transduced progenitors into IL-9 transgenic mice resulted in lymphoma formation and mastocytosis-like disease.
- IL-9 and NPM-ALK were found to upregulate mast cell production in vivo.
- Neoplastic mast cells in mice expressed IL-9 receptors, similar to human neoplastic mast cells.
Takeaway
This study shows that two factors, IL-9 and NPM-ALK, work together to make mice sick with a disease that affects their mast cells, which are important for the immune system.
Methodology
Mice were transplanted with NPM-ALK-transduced bone marrow cells and observed for tumor development and mast cell accumulation.
Limitations
The study was conducted in a mouse model, which may not fully replicate human disease.
Participant Demographics
Mice used included IL-9 transgenic and wild-type strains.
Want to read the original?
Access the complete publication on the publisher's website